CDKN2B and metabolic syndrome: Our findings also illustrated the association of lncRNA CDKN2B‐AS1 rs1333045T>C under the codominant, dominant, and log‐additive models with decreased risk of MetS after P value correction by the Benjamini & Hochberg method.